In addition to the complementary product lines, there are solid strategic advantages, such as geographical synergies and the combined strength of each other’s R&D departments.

To solidify this partnership, BioChek is in the process of acquiring a minority share of Bio-X.

Philippe Hivorel, CEO of Bio-X, comments: “This partnership will enable Bio-X to offer our products worldwide. Prior to this agreement, we worked with BioChek on several products and learned to appreciate BioChek’s collegial way of working”.

“We are pleased with this partnership,” adds Barend van Dam, CEO of BioChek, “The business philosophy of Bio-X and BioChek is very similar. State-of-the-art diagnostics and top-class support for our customers; that’s what we work for”.  

About Bio-X Diagnostics

Bio-X Diagnostics brings its 25-year experience and know-how in the veterinary diagnostic field to serve your needs and projects. Our products are carefully designed and manufactured in conformity with various standardized testing protocols (laboratory product range) and to meet market demand for rapid detection (point-of-care product range). What sets us apart is our Flexibility, Curiosity, and Perseverance, which we apply daily to support Veterinarians and Professionals in the Animal Health industry.

About BioChek 

BioChek’s extensive portfolio of veterinary diagnostics for poultry and swine diseases is used worldwide. Our head office is based in the Netherlands, with an R&D department and production facility in the UK, a USDA-licensed facility in the USA, a regional office in South Africa, regional and local sales teams, and numerous distributors. BioChek can support the poultry and swine industries to help improve livestock productivity and ultimately promote animal health.

Namur & Reeuwijk | 27 August 2024